We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ALPA.NSE

Price
105.96
Stock movement up
+4.12 (4.05%)
Company name
Alpa Laboratories Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
2.23B
Ent value
2.57B
Price/Sales
2.29
Price/Book
1.35
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
10.70
Forward P/E
-
PEG
-
EPS growth
84.07%
1 year return
13.51%
3 year return
14.74%
5 year return
52.97%
10 year return
23.34%
Last updated: 2025-04-12

DIVIDENDS

ALPA.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E10.70
Price to OCF168.44
Price to FCF168.44
Price to EBITDA91.65
EV to EBITDA105.73

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales2.29
Price to Book1.35
EV to Sales2.64

FINANCIALS

Per share

Per share data
Current share count21.04M
EPS (TTM)9.92
FCF per share (TTM)0.63

Income statement

Income statement data
Revenue (TTM)972.97M
Gross profit (TTM)234.96M
Operating income (TTM)75.33M
Net income (TTM)208.27M
EPS (TTM)9.92
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)24.15%
Operating margin (TTM)7.74%
Profit margin (TTM)21.41%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.11M
Net receivables0.00
Total current assets1.77B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets1.99B
Accounts payable173.60M
Short/Current long term debt22.61M
Total current liabilities319.60M
Total liabilities343.55M
Shareholder's equity1.65B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)13.24M
Capital expenditures (TTM)0.00
Free cash flow (TTM)13.24M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity12.65%
Return on Assets10.47%
Return on Invested Capital12.48%
Cash Return on Invested Capital0.79%

STOCK INFORMATION

Stock chart

Stock price data
Open103.99
Daily high108.39
Daily low103.99
Daily Volume24K
All-time high3501.00
1y analyst estimate-
Beta1.04
EPS (TTM)9.92
Dividend per share-
Ex-div date-
Next earnings date26 May 2025

Downside potential

Downside potential data
ALPA.NSES&P500
Current price drop from All-time high-96.97%-12.89%
Highest price drop-99.85%-56.47%
Date of highest drop19 Jun 20139 Mar 2009
Avg drop from high-89.79%-11.07%
Avg time to new high1065 days12 days
Max time to new high2849 days1805 days
COMPANY DETAILS
ALPA.NSE (Alpa Laboratories Limited) company logo
Marketcap
2.23B
Marketcap category
Mid-cap
Description
Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. The company sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. It also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. The company was founded in 1967 and is based in Indore, India.
Employees
410
Website
https://www.alpalabs.in
Investor relations
-
SEC filings
ALPA.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved